• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血液透析作为肾脏替代治疗]

[Hemodialysis as kidney replacement therapy].

作者信息

Descoeudres C

机构信息

Abteilung für Dialyse und Transplantation, Medizinische Poliklinik der Universität Bern.

出版信息

Schweiz Med Wochenschr. 1989 Aug 8;119(31-32):1067-70.

PMID:2678441
Abstract

Haemodialysis is the most frequently used renal replacement therapy and in Europe keeps alive more than 80,000 patients with end-stage renal failure. Three times weekly the patient is connected to the artificial kidney and uraemic toxins are removed using a filter permeable for water and small solutes. This treatment lasts about 3-4 hours and can be performed in hospitals, dialysis centers or in the patient's own home. With haemodialysis, patients can survive for many years with a good quality of life. However, dialysis treatment is time-consuming, there are dietary restrictions, and the patients become increasingly dependent on medical personnel and relatives. It is therefore not surprising that most dialysis patients hope for a kidney transplantation.

摘要

血液透析是最常用的肾脏替代疗法,在欧洲,它维持着8万多名终末期肾衰竭患者的生命。患者每周三次连接到人工肾,通过对水和小分子溶质可渗透的滤器清除尿毒症毒素。这种治疗持续约3 - 4小时,可以在医院、透析中心或患者自己家中进行。通过血液透析,患者可以高质量地生活多年。然而,透析治疗耗时,有饮食限制,患者对医护人员和亲属的依赖也日益增加。因此,大多数透析患者希望进行肾脏移植也就不足为奇了。

相似文献

1
[Hemodialysis as kidney replacement therapy].[血液透析作为肾脏替代治疗]
Schweiz Med Wochenschr. 1989 Aug 8;119(31-32):1067-70.
2
[Renal replacement therapy by hemodialysis: an overview].[血液透析的肾脏替代治疗:概述]
Nephrol Ther. 2009 Jul;5(4):306-12. doi: 10.1016/j.nephro.2009.03.001. Epub 2009 May 28.
3
Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.影响选择不接受透析的晚期慢性肾病患者生存的因素。
Ren Fail. 2007;29(6):653-9. doi: 10.1080/08860220701459634.
4
Quality of life of patients having renal replacement therapy.接受肾脏替代治疗的患者的生活质量。
J Adv Nurs. 2005 Jul;51(1):15-21. doi: 10.1111/j.1365-2648.2005.03455.x.
5
Advances and innovations in dialysis in the 21st century.21世纪透析技术的进展与创新。
Postgrad Med J. 2009 Feb;85(1000):102-7. doi: 10.1136/pgmj.2008.071837.
6
Choosing therapy for end-stage renal disease.选择终末期肾病的治疗方法。
Am Fam Physician. 1983 Jul;28(1):115-24.
7
[Different strategies of substitute treatment of end-stage chronic kidney failure by dialysis].[终末期慢性肾衰竭透析替代治疗的不同策略]
Rev Prat. 1991 Apr 21;41(12):1050-4.
8
Management of elderly patients with end-stage kidney disease.老年终末期肾病患者的管理。
Semin Nephrol. 2009 Nov;29(6):643-9. doi: 10.1016/j.semnephrol.2009.07.009.
9
[The past, the present and the future of renal replacement therapy].
Vnitr Lek. 2011 Jul-Aug;57(7-8):603-6.
10
The effect of increasing dialysis dose in overweight hemodialysis patients on quality of life: a 6-week randomized crossover trial.增加透析剂量对超重血液透析患者生活质量的影响:一项为期6周的随机交叉试验。
Am J Kidney Dis. 2008 May;51(5):796-803. doi: 10.1053/j.ajkd.2007.12.031. Epub 2008 Apr 2.